Sarcoidosis with Cancer Immunotherapy, Mistaken for Cancer Progression
Cancer immunotherapy with Opdivo (nivolumab) and Yervoy (ipilimumab) may or may not trigger sarcoidosis in rare cases, a report from Yale University School of Medicine shows. The study, “Immune-related sarcoidosis observed in combination ipilimumab and nivolumab therapy,” published in the Journal of the American Academy of…